Provider review
Welling Health review
States its pharmacy class six times and puts the price in the page title.
What the figure includes is never stated, so you know the cost and not what it buys.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Welling Health
$190/mo compounded GLP-1, 503A stated repeatedly
- Vs median
- $21/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A stated
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things stand out here and both are about disclosure rather than price. The figure sits in the page title, which is an odd place for a price and an effective one: it is the first thing a search result shows and it cannot be quietly adjusted without changing what the page is called. And the pharmacy class is stated repeatedly rather than once — the 503A designation appears six times across the site, with a 503B reference beside it, in a field where most sellers name no class at all and several mention one only in a footnote nobody reads. What is missing is the middle of the story. The figure has no term attached, no supply length, and no list of what it covers, so you know what it costs and not what you get for it. Whether a consultation, shipping or supplies sit inside that number is not answered anywhere on the front page, and no milligram appears against it either.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the pharmacy class stated plainly and repeatedly before you commit
- You prefer one monthly figure to a promotional ladder
- You want a price you can see without an intake
Look elsewhere if
- You want to know what the figure includes. It is not stated
- You want a supply length or a term attached to the price
- You want a dose behind the number
What it actually costs
Price as published
$190/mo for compounded GLP-1 therapy, printed in the page title itself alongside the certification claim — "Welling Health — Compounded GLP-1 Therapy | $190/mo | LegitScript Certified" · ★ the 503A designation appears six times across the site, which is more than any other row here states about its own pharmacy class, and a 503B reference sits beside it · the figure carries no term, no supply length and no statement of what it includes, so what the $190 buys is not established anywhere on the front page · no milligram is published
- Vs median
- $21/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. One monthly figure, no ladder and no low-dose product. ★ What distinguishes it is pharmacy disclosure rather than price structure: the 503A class is stated six times across the site, against a field where most name no class at all. The figure has no term, no supply length and no inclusion list, so a reader knows the cost and not what it covers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The price is in the page title, which makes it hard to change quietly.
- The 503A pharmacy class is stated repeatedly rather than mentioned once.
- A single monthly figure rather than a promotional ladder.
Pharmacy, labs and oversight
Welling Health dispenses through a 503A stated facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Welling Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things stand out and they are both about disclosure rather than price. The figure is in the page title, which is an odd place to put a price and an effective one — it is the first thing a search result shows and it cannot be quietly changed without changing what the page is called. And the pharmacy class is stated repeatedly rather than once: the 503A designation appears six times across the site, with a 503B reference beside it, against a field where most sellers name no class at all and several name one only in a footnote. What is missing is the middle of the story. The figure has no term attached, no supply length, and no list of what it covers, so a reader knows what it costs and not what it buys. Whether a consultation, shipping or supplies sit inside the $190 is not answered on the front page.
The honest cons
The figure carries no term and no supply length.
- What the price includes is not stated on the front page.
- No milligram is published against it.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Welling Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#308 of 373
Ordered with the companies that pay us first, and Welling Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.